Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses
NCT ID: NCT01444313
Last Updated: 2018-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses
NCT01444053
The Effects of Contact Lenses With UV/HEV-Filter on Visual Function
NCT05601544
Do Blue-Blocking Lenses Block Blue Colour From Our Lives?
NCT00403143
The Effect of a Blue Light Filtering IOL
NCT00571831
Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light
NCT05344560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
nelfilcon A OD / narafilcon A OS
Soft contact lens without UV protection worn on the right eye (OD) and soft contact lens with UV protection worn on the left eye (OS).
narafilcon A contact lens
Soft contact lenses with UV protection
nelfilcon A soft contact lenses
Soft contact lenses without UV protection
narafilcon A OD / nelfilcon A OS
Soft contact lens with UV protection worn on the right eye (OD) and soft contact lens without UV protection worn on the left eye (OS).
narafilcon A contact lens
Soft contact lenses with UV protection
nelfilcon A soft contact lenses
Soft contact lenses without UV protection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
narafilcon A contact lens
Soft contact lenses with UV protection
nelfilcon A soft contact lenses
Soft contact lenses without UV protection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject's spherical error equivalent (Best Sphere corrected for back vertex distance) must be from -0.50 diopters (D) to -6.00D or from +0.50D to +4.00D in each eye
* The subject must have a refractive astigmatism in each eye of -0.75D or less
* The subject must have a best corrected visual acuity of 6/9 or better in each eye.
* The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol
* The subject must read and sign the statement of informed consent
* The subject must be at least 18 years of age
Exclusion Criteria
* Systemic disease which might interfere with contact lens wear
* Ocular disease which might interfere with contact lens wear
* Grade 3 or 4 Slit Lamp Findings
* Greater than 0.1 difference in macular pigment optical density (MPOD) findings between right and left eye at baseline visit
* On changing stable medication or taking any medication known to affect tear film
* Active ocular surface pathology
* Use ocular medication
* Had had any anterior ocular surgery or other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study
* Significant ocular tissue anomaly
* Presence of two or more corneal scars in either eye
* Pregnancy or lactation, or intends to become pregnant during the time period of the study
* Any medical condition that may be prejudicial to the study
* Diabetes
* Infectious diseases (e.g. Hepatitis, tuberculosis)
* Contagious immunosuppressive diseases (e.g. HIV)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-201009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.